BackAlto Neuroscience Overview

Alto Neuroscience Current Cash

Alto Neuroscience's current cash is $240M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$243.73M
↑ 65.15% YoYΔ $96.15M vs prior year quarter

Peer trimmed avg / median

Loading

Alto Neuroscience Current Cash History

Loading

Alto Neuroscience vs. peers: Current Cash Comparison

Loading

Alto Neuroscience Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Alto Neuroscience (ANRO) FAQ

As of the most recent data (June 2026), ANRO shows a current cash of $240M. That compares with $150M in the prior-year period — up 65.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ANRO's current cash is now $240M (was $150M) — a 65.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Alto Neuroscience is outperforming or lagging.

Tracking ANRO's current cash over time shows whether Alto Neuroscience is scaling, shrinking, or reshaping that part of the business. The current reading is $240M That compares with $150M in the prior-year period — up 65.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Alto Neuroscience's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $240M) with ownership activity and broader fundamentals.